Activation of NADPH oxidase in adipocytes and resident macrophages contributes to the inflammation that compromises adipocyte insulin sensitivity, which in turn leads to the excess flux of free fatty acids that promotes systemic insulin resistance and hyperlipidemia [1,18,43]. Here, FMO5 is linked to Insulin resistance.